MacroGenics | MGNX - Current Assets

Stock Price
1.74
Daily Change
-0.01 -0.57%
Monthly
1.16%
Yearly
-38.95%
Q1 Forecast
1.77

MacroGenics reported $232.09M in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
AbbVie USD 28.54B 722M Sep/2025
Amgen USD 27.88B 1.15B Sep/2025
AstraZeneca USD 29.94B 1B Sep/2025
Biogen USD 8.94B 968.9M Sep/2025
Bristol-Myers Squibb USD 35.63B 2.41B Sep/2025
Daiichi Sankyo JPY 2.1T 218.5B Dec/2025
Eli Lilly USD 62.07B 12.22B Sep/2025
Genmab DKK 3.91B 127M Jun/2025
Geron USD 522.34M 16.75M Sep/2025
Gilead Sciences USD 18.84B 4.12B Sep/2025
J&J USD 54.61B 113M Sep/2025
MacroGenics USD 232.09M 27.15M Sep/2025
Merck USD 47.56B 10.49B Sep/2025
Pfizer USD 46.92B 3.22B Sep/2025
Regeneron Pharmaceuticals USD 17.98B 1.12B Sep/2025
Roche Holding CHF 38.73B 3.03B Dec/2025
Xencor USD 518.44M 5.29M Sep/2025